Common Presence of Non–Transferrin-Bound Iron Among Patients With Type 2 Diabetes
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Recently, we reported increased cardiovascular disease mortality among supplemental vitamin C users with type 2 diabetes in a prospective cohort study. Because vitamin C may cause oxidative stress in the presence of redox active iron, we hypothesized that non–transferrin-bound iron (NTBI), a form of iron susceptible to redox activity, may be present in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS—We measured serum NTBI levels using high-performance liquid chromatography in 48 patients with known diabetes (at least 5 years duration since diagnosis), 49 patients with newly diagnosed diabetes, and 47 healthy control subjects (frequency matched on age and sex). RESULTS—NTBI was commonly present in diabetes: 59% in newly diagnosed diabetes and 92% in advanced diabetes. Mean NTBI values varied significantly between the three groups, with the highest values being observed in patients with known diabetes and the lowest in the control subjects (0.62 ± 0.43 vs. 0.24 ± 0.29 vs. 0.04 ± 0.13 μmol/l Fe). Serum total iron or percent transferrin saturation were very similar among the three groups, yet NTBI was strongly associated with serum total iron (r = 0.74, P < 0.01) and percent transferrin saturation (r = 0.70, P < 0.01) among the patients with known diabetes. CONCLUSIONS—Consistent with our hypothesis, these data demonstrate the common existence of NTBI in type 2 diabetic patients with a strong gradient with severity. Prospective cohort studies are required to clarify the clinical relevance of increased NTBI levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Non-transferrin-bound iron is also considerably elevated in type 2 diabetes [621], and this too is exacerbated by vitamin C.”
Citations
Cites
Glucose Toxicity in β-Cells: Type 2 Diabetes, Good Radicals Gone Bad, and the Glutathione Connection
Robertson, R. P., Harmon, J., Tran, P. O., Tanaka, Y., & Takahashi, H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.581 · Cited by 897
Does vitamin C act as a pro‐oxidant under physiological conditions?
Carr, A., & Frei, B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9.1007 · Cited by 884
Vitamin C exhibits pro-oxidant properties
Podmore, I. D., Griffiths, H. R., Herbert, K. E., Mistry, N., Mistry, P., & Lunec, J. (1998) · Nature · doi:10.1038/33308 · Cited by 800
Cross-Talk Between Iron Metabolism and Diabetes
Fernández-Real, J. M., López-Bermejo, A., & Ricart, W. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2348 · Cited by 704
Commentary: Vitamin C: Antioxidant or Pro-Oxidant In Vivo?
Halliwell, B. (1996) · Free Radical Research · doi:10.3109/10715769609149066 · Cited by 531
Blood Letting in High-Ferritin Type 2 Diabetes
Fernández-Real, J. M., Peñarroja, G., Castro, A., García-Bragado, F., Hernández-Aguado, I., & Ricart, W. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1000 · Cited by 334
The importance of non-transferrin bound iron in disorders of iron metabolism
Breuer, W., Hershko, C., & Cabantchik, Z. I. (2000) · Transfusion Science · doi:10.1016/s0955-3886(00)00087-4 · Cited by 270
Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes?
Lee, D.-H., Folsom, A. R., Harnack, L., Halliwell, B., & Jacobs, D. R. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.5.1194 · Cited by 199
Self-citationQuantification of Non-Transferrin-Bound Iron in the Presence of Unsaturated Transferrin
Gosriwatana, I., Loreal, O., Lu, S., Brissot, P., Porter, J., & Hider, R. C. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4216 · Cited by 168
Self-citationA non-transferrin-bound serum iron in idiopathic hemochromatosis
Batey, R. G., Fong, P. L. C., Shamir, S., & Sherlock, S. (1980) · Digestive Diseases and Sciences · doi:10.1007/bf01308057 · Cited by 162
Does diabetes mellitus increase the requirement for vitamin C?
Will, J. C., & Byers, T. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1996.tb03932.x · Cited by 156
Redox active plasma iron in C282Y/C282Y hemochromatosis
Le Lan, C., Loréal, O., Cohen, T., Ropert, M., Glickstein, H., Lainé, F., Pouchard, M., Deugnier, Y., Le Treut, A., Breuer, W., et al. (2005) · Blood · doi:10.1182/blood-2004-09-3468 · Cited by 151
Will, J. C., Ford, E. S., & Bowman, B. A. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.1.49 · Cited by 116
Non‐transferrin‐bound iron is present in serum of hereditary haemochromatosis heterozygotes
Valk, D., Addicks, Gosriwatana, Lu, Hider, & Marx, M. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00628.x · Cited by 114
Jacobs, E. M. G., Hendriks, J. C. M., van Tits, B. L. J. H., Evans, P. J., Breuer, W., Liu, D. Y., Jansen, E. H. J. M., Jauhiainen, K., Sturm, B., Porter, J. B., et al. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.03.008 · Cited by 101
Self-citationBlood Letting in High-Ferritin Type 2 Diabetes
Fernández-Real, J. M., Peñarroja, G., Castro, A., García-Bragado, F., López-Bermejo, A., & Ricart, W. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2249 · Cited by 85
Scheiber-Mojdehkar, B., Lutzky, B., Schaufler, R., Sturm, B., & Goldenberg, H. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000130149.18412.56 · Cited by 60
Lee, D.-H., & Jacobs, D. R. (2004) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00344-x · Cited by 54
Self-citationNon‐Transferrin‐Bound Iron in Alcohol Abusers
de Feo, T. M., Fargion, S., Duca, L., Cesana, B. M., Boncinelli, L., Lozza, P., Cappellini, M. D., & Fiorelli, G. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02152.x · Cited by 48
Sulieman, M., Asleh, R., Cabantchik, Z. I., Breuer, W. V., Aronson, D., Suleiman, A., Miller‐Lotan, R., Hammerman, H., & Levy, A. P. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2730 · Cited by 34
Driss, F., Vrtovsnik, F., Katsahian, S., Michel, C., Baron, G., Kolta, A. M., Sedrati, N., Mentré, F., Mignon, F., Cabantchik, I. Z., et al. (2005) · Nephron Clinical Practice · doi:10.1159/000083208 · Cited by 11
(1998) · PubMed
Cited by
Advances in metal-induced oxidative stress and human disease
Jomova, K., & Valko, M. (2011) · Toxicology · doi:10.1016/j.tox.2011.03.001 · Cited by 3,207
Non-transferrin bound iron: a key role in iron overload and iron toxicity
Brissot, P., Ropert, M., Le Lan, C., & Loréal, O. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.014 · Cited by 654
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Battin, E. E., & Brumaghim, J. L. (2009) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-009-9054-7 · Cited by 476
The Role of Iron in Diabetes and Its Complications
Swaminathan, S., Fonseca, V. A., Alam, M. G., & Shah, S. V. (2007) · Diabetes Care · doi:10.2337/dc06-2625 · Cited by 423
Metadata
- Authors
- Lee, D.-H., Liu, D. Y., Jacobs, D. R., Shin, H.-R., Song, K., Lee, I.-K., Kim, B., & Hider, R. C.
- Affiliations
- Kyungpook National University (KR)
- King's College London (GB)
- University of Minnesota (US)
- National Cancer Center (KR)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2006-05-01
- Volume
- 29
- Issue
- 5
- Pages
- 1090-1095
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2019742598
- Cited by
- 128
- References
- 22
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 7 · 2021: 12 · 2020: 7 · 2019: 6 · 2018: 5 · 2017: 4 · 2016: 8 · 2015: 7 · 2014: 16 · 2013: 6 · 2012: 8
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- non-transferrin-bound iron, type 2 diabetes, oxidative stress, vitamin C supplementation, cardiovascular mortality, transferrin saturation, newly diagnosed diabetes, disease severity
- MeSH terms
- C-Reactive Protein, Diabetes Mellitus, Type 2, Female, Ferritins, Humans, Iron, Male, Middle Aged, Reference Values, Transferrin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.